ClinicaSpace.com
Clinical Research
News & Careers
 
Search the Site
    
 
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   

By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile

 

Astellas Pharma Inc. 

3-11 Nihonbashi-Honcho 2-chome

Chuo-ku  Tokyo  103-8411  Japan
Phone: 81-3-3244-3000 Fax: 81-3-3244-3272


SEARCH JOBS


Industry
Healthcare

Segment
Pharmaceuticals





 Company News
Cancer Research Technology And Cancer Research UK Cambridge Research Institute Join Forces With Astellas Pharma Inc. (ALPMY) On Autophagy To Find New Cancer Treatments 8/8/2014 7:44:51 AM
Astellas Pharma Inc. (ALPMY) Details Pipeline Progress At R&D Meeting 7/11/2014 8:10:48 AM
Astellas Pharma Inc. (ALPMY) Details Pipeline Progress At R&D Meeting 7/11/2014 6:48:00 AM
Basilea Pharmaceutica (BSLN.SW)'s Partner Astellas Pharma Inc. (ALPMY) Submits Isavuconazole U.S. NDA For The Treatment Of Invasive Aspergillosis And Invasive Mucormycosis 7/9/2014 2:01:03 PM
Astellas Pharma Inc. (ALPMY) Submits U.S. New Drug Application For Isavuconazole For The Treatment Of Invasive Aspergillosis And Invasive Mucormycosis 7/9/2014 10:26:22 AM
Astellas Pharma Inc. (ALPMY) Returns To "Give Kids The World" And Expands Partnership With Starlight Children's Foundation To Brighten The Lives Of Young Patients & Their Families 6/11/2014 10:01:54 AM
Astellas Pharma Inc. (ALPMY) Release: The New England Journal of Medicine Publishes Results From Phase 3 PREVAIL Trial Of Enzalutamide In Men With Chemotherapy-Naïve Metastatic Prostate Cancer 6/2/2014 10:14:25 AM
Astellas Pharma Inc. (ALPMY) And Medivation, Inc. (MDVN) Receive Priority Review From FDA For XTANDI® (Enzalutamide) Capsules In Chemotherapy-Naive Advanced Prostate Cancer 5/6/2014 9:34:58 AM
Astellas Pharma Inc. (ALPMY) Makes $7.3 Million Deal With U.S. Department Of Justice 4/17/2014 6:34:32 AM
Astellas Pharma Inc. (ALPMY) Announces Marketing Approval In Japan For XTANDI® (Enzalutamide) Capsules, An Advanced Prostate Cancer Treatment 3/25/2014 6:47:44 AM
12345678910...